Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M193Revenue $M4.4Net Margin (%)-989.7Z-Score-3.9
Enterprise Value $M216EPS $-0.8Operating Margin %-1,262.6F-Score3
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-1,267.3Higher ROA y-yN
Price/Book11.610-y EBITDA Growth Rate %34.0Quick Ratio1.6Cash flow > EarningsY
Price/Sales30.75-y EBITDA Growth Rate %62.8Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-76.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-296.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M72.2ROI % (ttm)-119.2Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 56.

No Entry found!

BTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WEST MICHAEL DCEO 2014-07-22Sell270,000$2.653.77 view
Peabody RobertSr. VP, COO, and CFO 2014-07-22Sell100,000$2.653.77 view
TEW WILLIAM P PHDChief Commercial Officer 2014-06-17Sell30,000$3.07-10.42 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-06-16Buy1,000,000$2.510 view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2014-05-16Sell300,000$2.4512.24 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-16Buy300,000$2.4512.24 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-08Buy300,000$2.4412.7 view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2014-05-08Sell300,000$2.4412.7 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-01Buy2,000,000$2.529.13 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-02-25Buy500,000$3.74-26.47 view

Press Releases about BTX :

    Quarterly/Annual Reports about BTX:

    News about BTX:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

    More From Other Websites
    BioTime Announces Issuance of 14 Patents in the Fields of Regenerative Medicine, and Cancer... Jul 14 2014
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Jul 14 2014
    BioTime Announces Issuance of 14 Patents in the Fields of Regenerative Medicine, and Cancer... Jul 14 2014
    BioTime Announces Issuance of 14 Patents in the Fields of Regenerative Medicine, and Cancer... Jul 14 2014
    LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the... Jul 10 2014
    BIOTIME INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements... Jul 07 2014
    BioTime subsidiary Asterias Biotherapeutics raises $12.5M Jun 17 2014
    BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Jun 17 2014
    BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or... Jun 12 2014
    BioTime Subsidiary Asterias Biotherapeutics Appoints Former Pfizer Senior Executive Pedro Lichtinger... Jun 12 2014
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Jun 02 2014
    BioTime to Present at the Jefferies 2014 Global Healthcare Conference Jun 02 2014
    BIOTIME INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 30 2014
    BioTime's Subsidiary Asterias Biotherapeutics, Inc. Announces a $14.3 Million Strategic Partnership... May 30 2014
    BioTime unit settle patent interference proceedings May 28 2014
    BIOTIME INC Files SEC form 8-K, Other Events May 28 2014
    BioTime’s Subsidiary Asterias Biotherapeutics, Inc. Settles Patent Interference Proceedings May 28 2014
    BioTime receives ISO 13485 certification for medical devices May 28 2014
    BioTime Receives ISO 13485 Certification for Medical Devices May 28 2014
    BioTime Receives ISO 13485 Certification for Medical Devices May 28 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide